Impala Pharma has announced plans for a global offering of 41.977 million H shares, with the maximum offering price set at HK$21.75 per share. The company expects its shares to begin trading on the Hong Kong Stock Exchange on May 13, 2026. Separately, China's bulk commodity price index rose by 1.7% in April, indicating a broader increase in commodity prices. AI
排序理由 The cluster contains unrelated news items about a pharmaceutical company's stock offering and China's commodity price index, with no clear AI angle.
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →